Funding Limits Will Force Choices At Device Evaluation Office – Tillman
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center says it will meet its fiscal year 2006 submission review time performance goals, but other activities might be neglected, given anticipated revenue